Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Shares Outstanding (Weighted Average) (2016 - 2025)

Jaguar Health (JAGX) has disclosed Shares Outstanding (Weighted Average) for 11 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 303.72% to $1.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.5 million, a 303.72% increase, with the full-year FY2024 number at $294534.0, up 1809.95% from a year prior.
  • Shares Outstanding (Weighted Average) was $1.5 million for Q3 2025 at Jaguar Health, up from $779391.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $45.0 million in Q2 2021 to a low of $15421.0 in Q4 2023.
  • A 5-year average of $7.9 million and a median of $779391.0 in 2025 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): tumbled 98.82% in 2023, then surged 1809.95% in 2024.
  • Jaguar Health's Shares Outstanding (Weighted Average) stood at $596154.0 in 2021, then skyrocketed by 120.0% to $1.3 million in 2022, then crashed by 98.82% to $15421.0 in 2023, then soared by 1809.95% to $294534.0 in 2024, then surged by 413.75% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Shares Outstanding (Weighted Average) are $1.5 million (Q3 2025), $779391.0 (Q2 2025), and $626644.0 (Q1 2025).